Immunotherapy of Prostate Cancer: Facts and Hopes
نویسندگان
چکیده
منابع مشابه
Prostate Cancer Immunotherapy
Prostate cancer is one of the most commonly diagnosed cancers in men and also one of the leading causes of their cancer-related deaths. Despite recent advances in the treatment of metastatic castration resistant prostate cancer, agents providing durable disease control and long-term survival are still needed. Therefore, various anti-cancer immunotherapy approaches are being explored in prostate...
متن کاملProstate cancer immunotherapy.
The interaction between the immune system and prostate cancer has been an area of research interest for several decades. The recent U.S. Food and Drug Administration approval of 2 first-in-class proof-of-concept immunotherapies (sipuleucel-T and ipilimumab) has stimulated broader interest in manipulating immunity to fight cancer. In the context of prostate cancer, the immunotherapy strategies t...
متن کاملStudy of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy
Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potential immunotherapeutic target. To target the NGEP in prostate cancer, it is essential to investig...
متن کاملProstate cancer and prostate-specific antigen: facts, figures and commentary.
The following information was prepared and distributed as a handout at the ACLI Medical Section’s June 12, 1993, Tumor Marker Committee meeting in Boca Raton, Florida. The information was subsequently published in the September/October 1993 issue of Lincoln National Reinsurance Medical Resource (R) and is reprinted here with permission from Lincoln National Life Reinsurance Company. (Copyright ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2017
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-17-0019